Acelyrin

poison pill toxic poison

Biotech

Pliant, Acelyrin take ‘poison pills’ as Concentra buyout looms

With Concentra expanding its stock influence in Pliant and Acelyrin, the two biotechs have shored up their defences against a potential acquisition.

James Waldron Mar 14, 2025 10:01am

blocks with checks and crosses

Acelyrin turns down surprise Concentra buyout offer

Mar 4, 2025 10:26am

illustration of two arrows going in opposite directions

Concentra curveball intrudes on Acelyrin-Alumis merger

Feb 21, 2025 7:35am

MA strategy deal block push come together form

Acelyrin to be absorbed into Alumis in all-stock merger

Feb 7, 2025 5:35am

Sinking deal terminated sunk deal ends

Affibody regains drug, says ex-ally unable to capitalize on data

Feb 3, 2025 5:18am

Businessman puts his box of his belongs on the desk and holds a white letter

Acelyrin loses interest in izokibep, lays off 3rd of staff

Aug 13, 2024 4:00pm